---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-037600"
form_type: "8-K"
ticker: "AIXC"
cik: "0001460702"
company_name: "AIxCrypto Holdings, Inc."
filed_at: "2024-09-20T23:59:59+00:00"
generated_at: "2026-05-31T02:46:33.454566+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Qualigen Therapeutics receives Nasdaq extension to continue listing through November 19, 2024

## Summary
- Received Nasdaq Hearings Panel notice on Sept 11, 2024 granting extension for continued listing.
- Must evidence compliance with all applicable Nasdaq criteria by November 19, 2024.
- Company is diligently working to fulfill requirements for continued listing on Nasdaq.

## SEC filing metadata
- accession: 0001493152-24-037600
- form_type: 8-K
- ticker: AIXC
- cik: 0001460702
- company_name: AIxCrypto Holdings, Inc.
- filed_at: 2024-09-20T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1460702/000149315224037600/0001493152-24-037600-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1460702/000149315224037600/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-037600
- JSON: https://secwatch.observer/filing/0001493152-24-037600.json
- Plain text: https://secwatch.observer/filing/0001493152-24-037600.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.